Also from this source

You just read:

SELLAS Life Sciences Announces Orphan Drug Designation for WT1 Cancer Vaccine in Patients with Acute Myeloid Leukemia (AML)

News provided by

SELLAS Life Sciences Group

Jan 11, 2016, 08:00 EST